Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddharth M Patel

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
JAMA Cardiology|October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-ITSiddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
JACC. Advances|December 18, 2023
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 TrialSiddharth M Patel, Marc P Bonaca, David A Morrow, et al.
American Journal of Epidemiology|October 9, 2025
Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trialsRobert Thiesmeier, Paul M Haller, Siddharth M Patel, et al.
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2015
Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesionsNagendra R Pokala, Rohan V Menon, Siddharth M Patel, et al.
The Journal of Invasive Cardiology|February 10, 2015
Prevalence and treatment of "balloon-uncrossable" coronary chronic total occlusionsSiddharth M Patel, Nagendra R Pokala, Rohan V Menon, et al.
JACC. Heart Failure|May 7, 2025
Rationale and Design of the Dapagliflozin Effect on Cardiovascular Events in Acute Heart Failure (DAPA ACT HF)-TIMI 68 TrialDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Blood|May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71Andre Maurice Small, Siddharth M Patel, Robert P Giugliano, et al.
JAMA Cardiology|September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical TrialSiddharth M Patel, Robert P Giugliano, David A Morrow, et al.
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
JAMA Cardiology|October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-ITSiddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
JACC. Advances|December 18, 2023
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 TrialSiddharth M Patel, Marc P Bonaca, David A Morrow, et al.
American Journal of Epidemiology|October 9, 2025
Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trialsRobert Thiesmeier, Paul M Haller, Siddharth M Patel, et al.
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2015
Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesionsNagendra R Pokala, Rohan V Menon, Siddharth M Patel, et al.
The Journal of Invasive Cardiology|February 10, 2015
Prevalence and treatment of "balloon-uncrossable" coronary chronic total occlusionsSiddharth M Patel, Nagendra R Pokala, Rohan V Menon, et al.
JACC. Heart Failure|May 7, 2025
Rationale and Design of the Dapagliflozin Effect on Cardiovascular Events in Acute Heart Failure (DAPA ACT HF)-TIMI 68 TrialDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Blood|May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71Andre Maurice Small, Siddharth M Patel, Robert P Giugliano, et al.
JAMA Cardiology|September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical TrialSiddharth M Patel, Robert P Giugliano, David A Morrow, et al.
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.
Pageof 5